Gyorgyi Osztrovszky

CarboCalyx is a pharmaceutical company dedicated to establish a novel personalized immunotherapy to combat cancer. I managed the overall operations and resources of the company. I made major decisions regarding R&D activities and business development. I established and coordinated external collaboration relationships. I acted as the main point of communication between the shareholders and corporate operations.

CarboCode is a glycotechnology-based company focusing on the production and commercialization of glycosphingolipids for cosmetic and nutrition applications. As being Co-Founder and CSO, I participated in the establishment of the company and it's growth to a group organization with 60+ employees. I drove the scientific development promoting innovative methodologies of new products development covering chemical, enzymatic and biotechnology processes. I coordinated the R&D activities of 6 departments (chemistry, biocatalysis, protein engineering, strain development, fermentation and analytical). I built-up international business networks suitable for intensive CRO and CMO works. I took part of the business development of the company as one of the Managing Directors.

Glycom is a pioneer glyco-biotechnology company, dedicated to produce Human Milk Oligosaccharides (HMOs) for infant nutrition market and for adult applications. Glycom became a worlds leading HMO supplier and was acquired by DSM in 2019. As project manager, I was responsible for developing a chemical synthetic route from mg scale to industrial production of 2-fucosyllactose (2FL) for infant nutrition. I was involved in the biotechnology development including recombinant oligosaccharide synthesis, upstream and downstream processes and isolation methodologies. I got insight in regulatory and GMP production.